Search research articles
Contact Us
Filters
Showing results (41-50 of 109) with videos related to
Page
of 11
Sort By:
Advances in Experimental Medicine and Biology
|
January 1, 1985
Risk factors for the development of premature cardiovascular disease
H B Brewer, D L Sprecher, R E Gregg, et al.
Science (New York, N.Y.)
|
February 6, 1981
Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E
R E Gregg, L A Zech, E J Schaefer, et al.
Genomics
|
October 1, 1990
A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy
W C Nichols, R E Gregg, H B Brewer, et al.
Hepatology (Baltimore, Md.)
|
November 1, 1984
Morphologic features of the liver in abetalipoproteinemia
M I Avigan, K G Ishak, R E Gregg, et al.
Biochimica Et Biophysica Acta
|
October 17, 1989
Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia
W A Mann, R E Gregg, D L Sprecher, et al.
Journal of Lipid Research
|
June 1, 1992
Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster
C M Arbeeny, D S Meyers, K E Bergquist, et al.
Toxicology and Applied Pharmacology
|
July 1, 1997
HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture
O P Flint, B A Masters, R E Gregg, et al.
The Journal of Clinical Investigation
|
June 1, 1986
Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis
R E Gregg, W E Connor, D S Lin, et al.
Child Nephrology and Urology
|
January 1, 1991
Severe hyperlipidemia due to multiple factors in a child with nephrotic syndrome
J R Ongkingco, W A Mann, E J Ruley, et al.
Biochemical and Biophysical Research Communications
|
January 29, 1986
ApoE deficiency: markedly decreased levels of cellular ApoE mRNA
J M Anchors, R E Gregg, S W Law, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 109) with videos related to
Sort By:
Page
of 11
Advances in Experimental Medicine and Biology
|
January 1, 1985
Risk factors for the development of premature cardiovascular disease
H B Brewer, D L Sprecher, R E Gregg, et al.
Science (New York, N.Y.)
|
February 6, 1981
Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E
R E Gregg, L A Zech, E J Schaefer, et al.
Genomics
|
October 1, 1990
A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy
W C Nichols, R E Gregg, H B Brewer, et al.
Hepatology (Baltimore, Md.)
|
November 1, 1984
Morphologic features of the liver in abetalipoproteinemia
M I Avigan, K G Ishak, R E Gregg, et al.
Biochimica Et Biophysica Acta
|
October 17, 1989
Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia
W A Mann, R E Gregg, D L Sprecher, et al.
Journal of Lipid Research
|
June 1, 1992
Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster
C M Arbeeny, D S Meyers, K E Bergquist, et al.
Toxicology and Applied Pharmacology
|
July 1, 1997
HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture
O P Flint, B A Masters, R E Gregg, et al.
The Journal of Clinical Investigation
|
June 1, 1986
Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis
R E Gregg, W E Connor, D S Lin, et al.
Child Nephrology and Urology
|
January 1, 1991
Severe hyperlipidemia due to multiple factors in a child with nephrotic syndrome
J R Ongkingco, W A Mann, E J Ruley, et al.
Biochemical and Biophysical Research Communications
|
January 29, 1986
ApoE deficiency: markedly decreased levels of cellular ApoE mRNA
J M Anchors, R E Gregg, S W Law, et al.
Page
of 11